Low-Intensity Focused Ultrasound for Epilepsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is an invite only study looking at the effects of Low-Intensity Focused Ultrasound (LIFU) on epilepsy patients with implanted electrodes under the care of Dr. Shah.
Who Is on the Research Team?
Aashit Shah, MD
Principal Investigator
Carilion Clinic
Are You a Good Fit for This Trial?
This trial is for individuals with hard-to-treat focal epilepsy originating in the mesial temporal region who have internet access, an RNS system implanted in the hippocampus, and prior head MRI and CT scans. They must be able to consent for themselves.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Low-Intensity Focused Ultrasound (LIFU) stimulation targeting the entorhinal cortex to assess effects on seizure frequency and cognitive functions.
Follow-up
Participants are monitored for seizure frequency and cognitive function changes using the implanted RNS system and neuropsychological tests.
What Are the Treatments Tested in This Trial?
Interventions
- Low-Intensity Focused Ultrasound
Trial Overview
The study examines Low-Intensity Focused Ultrasound (LIFU) neuromodulation effects on epilepsy patients with implanted electrodes. It's invite-only under Dr. Shah's care, comparing LIFU treatment against a sham procedure.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Low-intensity focused ultrasound will be applied to the entorhinal cortex in a pre/post design.
Sham Low-intensity focused ultrasound will be applied to the entorhinal cortex in a pre/post design.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Carilion Clinic
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.